Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation
Jaime Sanz(Hospital Universitari i Politècnic La Fe), Guillermo Sanz(Instituto de Salud Carlos III), Alessandra Algarotti(Azienda Ospedaliero-Universitaria delle Marche), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), David Valcárcel(Vall d'Hebron Hospital Universitari), Alessandra Picardi(University of Rome Tor Vergata), Marta González‐Vicent(Hospital Infantil Universitario Niño Jesús), Chiara Nozzoli, William Arcese(University of Rome Tor Vergata), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Carmen Martín(Hospital Universitario Reina Sofía), Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Benedetta Bartolozzi(Azienda Ospedaliero-Universitaria Careggi), Amparo Verdeguer(Leitat Technological Center), David Serrano(Hospital General Universitario Gregorio Marañón), Raquel de Paz(Hospital Universitario La Paz), Pau Montesinos(Instituto de Salud Carlos III), Christelle Ferrá(Hospital Universitari Germans Trias i Pujol), María Pascual(Universitat de València)
Cited by 26
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k